May 4, 2022 | Events, neurotechnology, Science in Society, Science Policy, Synthetic Biology
Markus Schmidt from Biofaction was invited as a guest speaker at the OECD workshop titled “Human augmentation: a challenge for governance?” The workshop was part of the 15th Session of the working party on Biotechnology, Nanotechnology and Converging...
Apr 28, 2022 | Events, Science in Society, Synthetic Biology
Biofaction was invited by the Marie Curie ITN Training School PERICO April 26-28, 2022, in Berlin at Lifeglimmer, to train 15 ITN Early Stage Researchers. This was the last of a series of transferable skills training courses where PhD students learned about career...
Dec 22, 2021 | announcement, art-science, Creative, News, science, Science in Society, Synthetic Biology
We are excited to be exhibiting once again at Museon, a museum of science and culture based in The Hague (the Netherlands)! Within their permanent “One Planet” exhibition we had the opportunity to create two new installations, each of them connected to one...
Sep 15, 2021 | Media, News, Science Communication, Science in Society
We created a new set of infographics for SinFonia, our EC funded research project to produce fluoropolymers in a biological way. The informative slides explain the project’s aims, methods and background in a simple and understandable way. Have a look at the...
Sep 15, 2021 | announcement, Media, neurotechnology, News, Publications, Science in Society
Berliner Zeitung interviewed Markus Schmidt about Neurotechnology and our ongoing FWF funded project Futurebody. Schmidt shared his views on the future of the human body and explained how humans will continue to merge with technology as well as what kind of...
Jun 1, 2021 | art-science, Creative, Film & Video, Media, neurotechnology, News, science, Science in Society
In a recent article of the science magazine Scilog the project FUTUREBODY was presented as the “project of the week”. “Connected brains, mood changes at the touch of a button, digital selves are discussed in an interview with Biofaction’s Markus Schmidt...
